Northridge, CA, United States of America

Jenn-Hann Larry Wang

This inventor holds 36 USPTO granted patents and 8 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Analyte Sensors. Top assignees: Medtronic Minimed, Inc., Ethicon, Gmbh, The University of Texas System. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jenn-Hann Larry Wang. Retrieved from https://idiyas.com/inventor/jenn-hann-larry-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 8)

% Patents Active = 88.9

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 3.2

ph-index = 17

Forward Citations = 1,547(Granted Patents)

Location History:

Arlington, TX (US) (1999 - 2001)
Mission Viejo, CA (US) (2001 - 2004)
Van Nuys, CA (US) (2002 - 2004)
Northridge, CA (US) (2007 - 2024)

Company Filing History:

19 out of 1,267

Medtronic Minimed, Inc.

The University of Texas System

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Analyte Sensors

Glucose Sensors

Electrochemical Impedance Spectroscopy

Sterilization Methods

Biosensors

Polycarbonate Polymers

Ketone Sensing

Non-Fouling Coatings

Surface Tailoring

Membrane Compositions

Microelectrogravimetry

Immunosuppressant Coatings

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527500 - Ketone limiting membrane and dual layer membrane approach for ketone sensing (2026-01-20),

2. 12419552 - Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods (2025-09-23),

3. 12201421 - Immunosuppressant releasing coatings (2025-01-21),

4. 12109023 - Thermally stable glucose limiting membrane for glucose sensors (2024-10-08),

5. 12023155 - Polycarbonate urea/urethane polymers for use with analyte sensors (2024-07-02),

6. 11730406 - Thermally stable glucose limiting membrane for glucose sensors (2023-08-22),

7. 11213231 - Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods (2022-01-04),

8. 11179078 - Polycarbonate urea/urethane polymers for use with analyte sensors (2021-11-23),

9. 11134872 - Thermally stable glucose limiting membrane for glucose sensors (2021-10-05),

10. 10660555 - Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods (2020-05-26),

11. 10342468 - Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods (2019-07-09),

12. 10335077 - Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods (2019-07-02),

13. 10335076 - Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods (2019-07-02),

14. 9863911 - Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods (2018-01-09),

15. 9408567 - Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods (2016-08-09),

Title: Innovations by Jenn-Hann Larry Wang: Leading the Charge in Implantable Device Technology

Introduction

Jenn-Hann Larry Wang is a prominent inventor based in Northridge, CA, renowned for his contributions to the field of biomedical engineering. With an impressive portfolio of 34 patents, Wang's innovations focus primarily on enhancing the functionality and biocompatibility of implantable devices, particularly glucose sensors.

Latest Patents

Wang's latest patents encompass groundbreaking technologies that improve the performance of analyte sensors. One such invention is the **Immunosuppressant Releasing Coatings**, which provides compositions useful in implantable devices like glucose sensors. These compositions incorporate one or more immunosuppressant agents within a polymeric material to enhance biocompatibility and functionality.

Another of his noteworthy patents is the **Thermally Stable Glucose Limiting Membrane for Glucose Sensors**. This innovation creates an analyte modulating membrane using a polymeric reaction mixture with specific amounts of catalyst and/or polycarbonate compounds. The result is improved thermal and hydrolytic stability, essential for the reliable operation of glucose sensors.

Career Highlights

Throughout his illustrious career, Jenn-Hann Larry Wang has made significant strides in medical technology. He has worked with esteemed companies such as Medtronic Minimed, Inc. and Ethicon, GmbH, where he contributed to the development of advanced medical devices. His expertise in polymer chemistry and biomedical applications has positioned him at the forefront of innovation in this field.

Collaborations

Wang has collaborated with other notable professionals in his industry, including Paul Taylor Jacobs and Rajiv Shah. These partnerships have fostered an environment of innovation and helped advance the technology surrounding implantable devices.

Conclusion

Jenn-Hann Larry Wang's dedication to innovation in implantable devices continues to impact the medical field significantly. His multiple patents demonstrate a strong commitment to enhancing the capabilities of glucose sensors and other analyte measuring technologies, ensuring better patient outcomes and advancing the realm of biomedical engineering.

Profile summary based on public USPTO records.